Final hours! Save up to 50% OFF InvestingProCLAIM SALE

Canada could deliver a COVID-19 vaccine to most by end of 2021, says top health official

Published 2020-11-17, 01:21 p/m
© Reuters. FILE PHOTO: Small bottles labeled with a "Vaccine COVID-19" sticker and a medical syringe are seen in this illustration

By Steve Scherer

OTTAWA (Reuters) - Canada has signed several agreements for potential COVID-19 vaccines and should be able to get them out to a large part of the population by the end of next year, one of Canada's top doctors said on Tuesday.

It is the first timeline for distribution of a vaccine that Ottawa has provided since Pfizer Inc (NYSE:PFE) last week and Moderna on Monday reported that their inoculation candidates had been extremely effective in preventing the spread of the novel coronavirus.

Canada has signed agreements https://www.reuters.com/article/idUSKBN27T1RS for millions of doses of each of these potential vaccines, which Prime Minister Justin Trudeau has said could start arriving in the country in the first quarter of next year for distribution to the highest risk and most vulnerable people. Canada's population is about 37.7 million, according to United Nations data.

But Canada has five more agreements for potential vaccines, and those could also become available next year after regulatory approval, Deputy Chief Medical Officer Howard Njoo told reporters, adding that it was an optimistic projection.

"If all goes well... we'll have a suite of vaccines available, and if we get delivery of those vaccines, I certainly can anticipate that as the year goes on ... (Canadians) will be able to be vaccinated and have a large part of the population covered by the end of the year," Njoo said.

It may take longer for Canadians to get the vaccine than Americans. Dr. Anthony Fauci, the top U.S. infectious disease expert, said this week that he expects mass inoculations to occur in May and June.

© Reuters. FILE PHOTO: Small bottles labeled with a

The Bank of Canada predicted last month, before Pfizer and Moderna preliminary test results were released, that "vaccines and effective treatments will be widely available by mid-2022".

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.